Michael brings more than 30 years of executive management experience in the life sciences and information technology industries. Michael is currently the Chief Strategy Officer for The Avoca Group. For the prior 5 years, Michael has been an early pioneer in the development and support of decentralized Clinical Trials, as President of AMC Health's CT Division. For the 10 years prior, Michael was COO then CEO of Beardsworth, a full service CRO with a primary focus in oncology. Michael has held CFO and CEO positions with three innovative life science companies focused in cord blood stem cells, resorbable polymer implants and microbicides. His high-technology experience based him in Paris and London. He began his career with Deloitte.